Clinical practice treatment of HIV infection in children

European Journal of Pediatrics

Volumn 168, Issue 4, 2009, Pages 387-392

  Brichard, Bénédicte ^a   Van Der Linden, Dimitri ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Antiretroviral therapy; Non nucleoside reverse transcriptase inhibitor; Nucleotide and nucleoside reverse transcriptase inhibitor; Pediatric HIV infection; Perinatal HIV infection; Protease inhibitor

Indexed keywords

ABACAVIR; ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; AMPRENAVIR; AMPRENAVIR PHOSPHATE; ATAZANAVIR; DARUNAVIR; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ETRAVIRINE; INDINAVIR; INTEGRASE INHIBITOR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; MARAVIROC; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RALTEGRAVIR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; TRIPANAVIR; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE;

CHILD; CHILDHOOD DISEASE; CLINICAL PRACTICE; DISEASE COURSE; DISEASE TRANSMISSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERINATAL CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; VERTICAL TRANSMISSION;

AGE FACTORS; ANTI-RETROVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; HIV FUSION INHIBITORS; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INTEGRASE INHIBITORS; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PROTEASE INHIBITORS; REVERSE TRANSCRIPTASE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 60449117506     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-008-0914-8     Document Type: Review

References (29)

1. ME Belzer DN Fuchs GS Luftman DJ Tucker 1999 Antiretroviral adherence issues among HIV-positive adolescents and young adults J Adolesc Health 25 316 319
2. S Blanche ML Newell MJ Mayaux 1997 Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study. J Acquir Immune Defic Syndr Hum Retrovirol 14 442 450
3. Centers for Disease Control and Prevention (CDC) 2007 Revised recommendations for HIV testing of adults, adolescents and pregnant women in health-care settings MMWR Recomm Rep 55 1 17
4. Centers for Disease Control and Prevention 1994 994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age MMWR Recomm Rep 43 1 10
5. Centers for Disease Control and Prevention 2001 Revised recommendations for HIV screening of pregnant women MMWR Recomm Rep 50 63 85
6. R Chakraborty 2005 HIV-1 infection in children: a clinical and immunologic overview Curr HIV Res 3 31 41
7. Cross Continents Collaboration for Kids (3Cs4kids) Analysis and Writing Committee 2008 Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis AIDS 22 97 105
8. H Dao LM Mofenson R Ekpini 2007 International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update Am J Obstet Gynecol 197 S42 S55
9. E Day K Buckberry MR Sharland R Chakraborty 2008 Novel treatment options for pediatric HIV infection Curr Opin Investig Drugs 9 170 175
10. J Durant P Clevenbergh P Halfon 1999 Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial Lancet 353 2195 2199
11. B Eley 2008 Metabolic complications of antiretroviral therapy in HIV-infected children Expert Opin Drug Metab Toxicol 4 37 49
12. B Eley J Nuttall 2007 Antiretroviral therapy for children: challenges and opportunities Ann Trop Paediatr 27 1 10
13. European Paediatric Lipodystrophy Group 2004 Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe AIDS 18 1443 1451
14. T Goetghebuer E Haelterman J Le Chenadec 2008 Early vs deferred highly active antiretroviral therapy in HIV infected infants: a European Collaborative Cohort Study Retrovirology 5 suppl 1 O25
15. C Giaquinto O Rampon M Penazzato 2007 Nucleoside and nucleotide reverse transcriptase inhibitors in children Clin Drug Investig 27 509 531
16. L Gray ML Newell C Thorne 2001 Fluctuations in symptoms in human immunodeficiency virus-infected children: the first 10 years of life Pediatrics 108 116 122
17. H Green DM Gibb AS Walker Paediatric European Network for the Treatment of AIDS (PENTA) 2007 Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children AIDS 21 947 955
18. HIV Paediatric Prognostic Markers Collaborative Study 2005 Use of total lymphocyte count for informing when to start antiretroviral therapy in HIV-infected children: a meta-analysis of longitudinal data Lancet 366 1868 1874
19. T Ikeda TW Ch'ng JM Oleske 2007 Recommendations in pediatric antiretroviral therapy Expert Opin Pharmacother 8 155 166
20. J Lujan-Zilbermann CA Rodriguez PJ Emmanuel 2006 Pediatric HIV infection: diagnostic laboratory methods Fetal Pediatr Pathol 25 249 260
21. K Luzuriaga M McManus L Mofenson PACTG 356 Investigators 2004 A trial of three antiretroviral regimens in HIV-1 infected children N Engl J Med 350 2471 2480
22. MS McKellar SF Callens R Colebunders 2008 Pediatric HIV infection: the state of antiretroviral therapy Expert Rev Anti Infect Ther 6 167 180
23. A Prendergast G Tudor-Williams P Jeena 2007 International perspectives, progress and future challenges of paediatric HIV infection Lancet 370 68 80
24. S Resino R Resino D Micheloud Spanish Group of Paediatric HIV infection 2006 Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up Clin Infect Dis 42 862 869
25. SE Starr CV Fletcher SA Spector PACTG 382 Study Team. Pediatric AIDS Clinical Trials Group 2002 Efavirenz liquid formulation in human immunodeficiency virus-infected children Pediatr Infect Dis J 21 659 663
26. D Van der Linden M Hainaut T Goetghebuer 2007 Effectiveness of early initiation of protease inhibitor-sparing antiretroviral regimen in human immunodeficiency virus-1 vertically infected infants Pediatr Infect Dis J 26 359 361
27. A Violari MF Cotton DM Gibb The CHER Study Team 2008 Early antiretroviral therapy and mortality among HIV-infected infants N Engl J Med 359 2233 2244
28. Working Group on Antiretroviral Therapy and Medical Management of HIV-infected children (2008) Guidelines for the use of antiretroviral gents in pediatric HIV infection and pediatric antiretroviral drug information. http://AIDSinfo.nih.gov
29. WHO (2008) Paediatric HIV and treatment of children living with HIV. www.who.int/hiv/paediatric/en/index.html